LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Biologics/Iowa Bio-Patch Regenerates Bone
Biologics

Iowa Bio-Patch Regenerates Bone

November 13, 2013 2 min read Premium comments

Advertisement

Iowa Bio-Patch Regenerates Bone
DNA and Particles / Source: Wikimedia Commons and L.A. Metskas
Secondary

Researchers at the University of Iowa have tested a “bio patch” that regenerates missing or damaged bone by inserting DNA into nano-sized particles that deliver bone-making instructions directly into cells.

According to Catherine Paddock, PhD., writing in MNT, the method succeeded in regrowing enough bone to cover skull wounds in live rats.

In test tubes it stimulated new growth in human bone marrow stromal cells. Paddock explained that, by using pieces of DNA that encode for a platelet-derived growth factor called PDGF-B, the researchers were able to deliver genetic instructions directly into living bone cells, causing them to make the proteins that lead to more bone production. They reported their work in the latest issue of the journal Biomaterials.

This study differed from previous ones in that it tackled cells from the inside, causing them to produce proteins that led to more bone growth. Previous work relied on repeated applications that deliver the bone-making proteins from the outside. This is costly, according to Paddock, and has to be done over and over again.

Corresponding author Aliasger Salem, Ph.D., professor at Iowa’s College of Pharmacy, explains: “If you deliver just the protein, you have to keep delivering it with continuous injections to maintain the dose. With our method, you get local, sustained expression over a prolonged period of time without having to give continued doses of protein.”

Paddock explained that to make their bio patch the team made a scaffold from collagen and seeded it with synthetically made, nano-sized plasmids, each carrying DNA pieces of genetic instructions for making bone. They then placed DNA-seeded and unseeded scaffolds onto small 5mm x 2mm holes in the skulls of rats. They found after four weeks that the seeded scaffolds grew 44 times more bone and soft tissue than did the unseeded scaffolds and 14 times more than untreated wounds.

Scans also revealed that the seeded scaffolds resulted in new bone growth that nearly closed the wound. They found that plasmids enter bone cells already present in the body which are located near the wound site and drift over to the scaffold. The researchers found the plasmids transport easily into cells once they are shrunk in size and given a positive electrical charge.

Salem explained that the delivery mechanism is the scaffold loaded with the plasmid. When cells migrate into the scaffold, they meet with the plasmid, take it up and get the encoding to start producing PDGF-B, which enhances bone regeneration.

A potential use for the bio patch could be to repair birth defects where bone is missing. The bio patch could be made in the shape and size of the defect site so when the new bone grows it will be a perfect fit.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy